Novavax Gets FDA's Fast Track Designation For Its RSV Vaccine For Older Adults

By: via Benzinga
Novavax, Inc. (NASDAQ: NVAX), a clinical-stage vaccine company, revealed Wednesday that the U.S. Food and Drug Administration has ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.